Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | KCNJ1 | P48048 | 1/20 | 0.33 |
| ▸ | P4HA1 | P13674 | 2/20 | 0.31 |
| ▸ | P4HTM | Q9NXG6 | 2/20 | 0.31 |
| ▸ | AKR1C3 | P42330 | 3/20 | 0.31 |
| ▸ | AKR1C2 | P52895 | 3/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.31 |
| ▸ | MIF | P14174 | 1/20 | 0.31 |
| ▸ | RXRA | P19793 | 3/20 | 0.30 |
| ▸ | GRIN1 | Q05586 | 3/20 | 0.30 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17553576 | 0.82 | ALDH1A1 (0.41) | ALDH1A1KDM4EL3MBTL1MAPTSMN1; SMN2 | |
| SCHEMBL19962271 | 0.78 | MAPK1 (0.39) | ALDH1A1KDM4EMAPTSMN1; SMN2 | |
| SCHEMBL17823927 | 0.76 | ALDH1A1 (0.39) | ALDH1A1KDM4EL3MBTL1SMN1; SMN2 | |
| SCHEMBL20771264 | 0.73 | NAPRT (0.38) | ALDH1A1KDM4EL3MBTL1ALOX15HSD17B10 | |
| SCHEMBL7993712 | 0.70 | CA5A (0.42) | ALDH1A1KDM4EL3MBTL1ALOX15HSD17B10 | |
| SCHEMBL12004072 | 0.68 | GRB2 (0.50) | ALDH1A1L3MBTL1MAPTSMN1; SMN2KMT2A | |
| SCHEMBL29131391 | 0.68 | KCNJ1 (0.39) | ALDH1A1KDM4EL3MBTL1ALOX15HSD17B10 | |
| SCHEMBL2175856 | 0.68 | KCNJ1 (0.39) | ALDH1A1KDM4EL3MBTL1ALOX15HSD17B10 | |
| SCHEMBL13160131 | 0.68 | CA5A (0.44) | ALDH1A1KDM4EL3MBTL1ALOX15HSD17B10 | |
| SCHEMBL10588749 | 0.67 | HCAR3 (0.42) | ALDH1A1KDM4EKMT2AKCNJ1HCAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230053411-A1 | 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2023-02-23 | — | — | US | disclosed |
| US-11142523-B2 | 1,3-thiazol-2-yl substituted benzamides | BAYER AKTIENGESELLSCHAFT (DE) | 2021-10-12 | — | — | US | disclosed |
| EP-3230281-B1 | 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES | BAYER AG (DE) | 2021-05-26 | — | — | EP | disclosed |
| US-20200131169-A1 | 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2020-04-30 | — | — | US | disclosed |
| US-10472354-B2 | 1,3-thiazol-2-yl substituted benzamides | BAYER AKTIENGESELLSCHAFT (DE) | 2019-11-12 | — | — | US | disclosed |
| US-20190185466-A1 | 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2019-06-20 | — | — | US | disclosed |
| US-10202369-B2 | 1,3-thiazol-2-yl substituted benzamides | BAYER AKTIENGESELLSCHAFT (DE) | 2019-02-12 | — | — | US | disclosed |
| US-10183937-B2 | 1,3-thiazol-2-yl substituted benzamides | BAYER AKTIENGESELLSCHAFT (DE) | 2019-01-22 | — | — | US | disclosed |
| US-10174016-B2 | 1,3-thiazol-2-yl substituted benzamides | BEYER AKTIENGESELLSCHAFT (DE) | 2019-01-08 | — | — | US | disclosed |
| US-20180118731-A1 | 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2018-05-03 | — | — | US | disclosed |
| US-20180093980-A1 | 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES | EVOTEC AG (DE) | 2018-04-05 | — | — | US | disclosed |
| US-20180072713-A1 | 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES | EVOTEC AG (DE) | 2018-03-15 | — | — | US | disclosed |
| EP-3230281-A1 | 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES | Bayer Aktiengesellschaft (DE) | 2017-10-18 | — | — | EP | disclosed |
| WO-2016091776-A1 | 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES | EVOTEC AG (DE) | 2016-06-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180093980-A1 | 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES | NAT1, HNMT, PMP22 | ALDH1A1 71/4885KDM4E 2654/4885L3MBTL1 2890/4885 |
| US-20230053411-A1 | 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES | NAT1, HNMT, PMP22 | ALDH1A1 71/4885KDM4E 2654/4885L3MBTL1 2890/4885 |
| US-20180118731-A1 | 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES | NAT1, HNMT, PMP22 | ALDH1A1 71/4885KDM4E 2654/4885L3MBTL1 2890/4885 |
| US-20190185466-A1 | 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES | NAT1, HNMT, PMP22 | ALDH1A1 71/4885KDM4E 2654/4885L3MBTL1 2890/4885 |
| US-10202369-B2 | 1,3-thiazol-2-yl substituted benzamides | NAT1, HNMT, PMP22 | ALDH1A1 71/4885KDM4E 2654/4885L3MBTL1 2890/4885 |
| US-10472354-B2 | 1,3-thiazol-2-yl substituted benzamides | NAT1, HNMT, PMP22 | ALDH1A1 71/4885KDM4E 2654/4885L3MBTL1 2890/4885 |
| US-10174016-B2 | 1,3-thiazol-2-yl substituted benzamides | NAT1, HNMT, PMP22 | ALDH1A1 71/4885KDM4E 2654/4885L3MBTL1 2890/4885 |
| US-10183937-B2 | 1,3-thiazol-2-yl substituted benzamides | NAT1, HNMT, PMP22 | ALDH1A1 71/4885KDM4E 2654/4885L3MBTL1 2890/4885 |
| US-11142523-B2 | 1,3-thiazol-2-yl substituted benzamides | NAT1, HNMT, PMP22 | ALDH1A1 71/4885KDM4E 2654/4885L3MBTL1 2890/4885 |
| US-20180072713-A1 | 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES | NAT1, HNMT, PMP22 | ALDH1A1 71/4885KDM4E 2654/4885L3MBTL1 2890/4885 |
| US-20200131169-A1 | 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES | NAT1, HNMT, PMP22 | ALDH1A1 71/4885KDM4E 2654/4885L3MBTL1 2890/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.